Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 8/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | NT5C2 | P49902 | 2/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.59 |
| ▸ | BRAF | P15056 | 2/20 | 0.58 |
| ▸ | TOP2A | P11388 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.54 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29475418 | 0.85 | BRAF (0.72) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL536913 | 0.85 | BRAF (0.72) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL5437612 | 0.85 | BRD4 (0.62) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL28669706 | 0.82 | NPC1 (0.63) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL28828155 | 0.82 | BRD4 (0.59) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL29514799 | 0.82 | BRD4 (1.00) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL23124 | 0.82 | BRD4 (1.00) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL1398283 | 0.81 | BRD4 (0.58) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL17362837 | 0.81 | BRD4 (0.58) | BRD4NPC1RAB9ANT5C2NT5E | |
| SCHEMBL8720615 | 0.81 | BRD4 (0.58) | BRD4NPC1RAB9ANT5C2NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003369-A1 | ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Brii Biosciences, Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| EP-3897667-A2 | SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020132603-A2 | SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2020-06-25 | — | — | WO | disclosed |
| CN-105829308-B | Isochromene derivatives as phosphoinositide 3-kinase inhibitors | 奇斯药制品公司 | 2019-03-08 | — | — | CN | disclosed |
| CN-107454902-A | Chromene derivative as the kinase inhibitor of phosphoinositide 3 | 奇斯药制品公司 | 2017-12-08 | — | — | CN | disclosed |
| CN-107337659-A | Compounds as protein kinase modulators | 理森制药股份公司 | 2017-11-10 | — | — | CN | disclosed |
| CN-103702989-B | Novel compounds as modulators of protein kinases | 理森制药股份公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-105358560-B | Dual selective PI3 and gamma kinase inhibitors | 理森制药股份公司 | 2017-03-08 | — | — | CN | disclosed |